Home - Belmore Neidrauer LLP

Persuasive Advocacy.
Proven Results.

We are experts in intellectual property litigation. We are trial lawyers.
We are appellate lawyers. We know patent law, inside and out.
Learn More

News

Peter Wilcox

It is with heartfelt sadness we share the passing of Belmore Neidrauer’s senior Partner and our dear friend Peter Wilcox. Peter was a fierce advocate for his clients, a deeply respected leader and force in the IP community, and an incredible mentor to our team and to many others in the profession.
Belmore Neidrauer Recognized by Best Law Firms™ - Canada

Belmore Neidrauer is pleased to be recognized in the inaugural edition of Best Law Firms™ - Canada. The listings highlight leading law firms for their exceptional performance across regions, practice areas and on a national scale.
Peter Wilcox awarded the Peter W. McBurney Memorial Award for Professional Excellence

We are proud to announce Peter Wilcox was recognized at the Intellectual Property Institute of Canada Conference in St. Johns, Newfoundland.
Chambers Canada Guide 2025 recognizes Belmore Neidrauer

We are proud to announce the firm has been recognized in the Chambers Canada Guide 2025 as a leader in Intellectual Property: Litigation.
Belmore Neidrauer Recognized by Best Lawyers in Canada™

The 2025 edition of Best Lawyers in Canada™ has recognized partners Peter Wilcox, Marian Wolanski and Stephanie Anderson as being amongst the leading lawyers in Canada (Intellectual Property Law).
Managing IP recognizes Peter Wilcox, Marian Wolanski and Stephanie Anderson as 2024 Patent Stars

We are proud to announce that our partners have been recognized by Managing IP as leaders in patent law, reinforcing Belmore Neidrauer’s status as a leader in the field.

Our Team

Renée draws on her background in health sciences to devise creative solutions to complex legal issues and advocate effectively for clients in patent litigation matters.
Renée Taillieu

Associate

p.(416) 863-3383

f.(416) 863-9171

e.rtaillieu@belmorelaw.com

See The Full Team

Our cases

February 16, 2024

Janssen Inc. v Pharmascience Inc.

Counsel: Peter Wilcox, Marian Wolanski, Megan Pocalyuko and Oleyna Strigul

Belmore Neidrauer secured another victory in the Federal Court of Appeal for our client Janssen relating to the validity of Janssen’s patent covering INVEGA SUSTENNA®
Read more
January 12, 2024

Janssen Inc. v Apotex Inc.

Counsel: Peter Wilcox, Marian Wolanski, Megan Pocalyuko and Oleyna Strigul

We successfully represented Janssen on another appeal relating to infringement of Janssen’s patent covering INVEGA SUSTENNA® (paliperidone palmitate) once-monthly injection product for the treatment of schizophrenia.
Read more
January 12, 2024

Janssen v. Pharmascience

Counsel: Peter Wilcox, Marian Wolanski, Megan Pocalyuko and Oleyna Strigul

We successfully represented Janssen in the Federal Court of Appeal on this appeal relating to infringement of the patent covering Janssen’s INVEGA SUSTENNA® (paliperidone palmitate) once-monthly injection product for the treatment of schizophrenia.
Read more
December 22, 2023

Janssen Inc. v Apotex Inc.

Counsel: Peter Wilcox, Marian Wolanski, Megan Pocalyuko and Oleyna Strigul

Belmore Neidrauer has successfully represented Janssen on another appeal, resulting in a decision overturning the Federal Court’s denial of summary judgment.
Read more
March 23, 2023

Janssen Inc. et al v. Teva Canada Limited

Counsel: Peter Wilcox, Marian Wolanski and Megan Pocalyuko

We successfully represented Janssen on Teva’s appeal and Janssen’s cross-appeal in a significant decision relating to the law of inducing patent infringement in Canada. The decision relates to Janssen’s patent covering INVEGA SUSTENNA® (paliperidone ...
Read more
October 27, 2022

Janssen v. Apotex

Counsel: Peter Wilcox and Stephanie Anderson

We successfully represented Janssen in a motion to appeal an order of the Associate Judge which declined, based on relevance, to compel Apotex to answer certain discovery questions related to its ability to supply its generic abiraterone acetate prod...
Read more
October 27, 2022

Janssen v. Apotex

Counsel: Peter Wilcox and Stephanie Anderson

We successfully represented Janssen in a motion to Amend its Statement of Defence in this PMNOC section 8 damages action. The Court agreed that Janssen was allowed to amend its Statement of Defence to raise issues as to Apotex’s ability to supply the...
Read more
December 05, 2022

Janssen v. Dr. Reddy

Counsel: Peter Wilcox and Stephanie Anderson

We successfully represented Janssen in this motion brought by Dr. Reddy’s in the context of a PMNOC section 8 damages action. Dr. Reddy’s was seeking to have a question of law determined before trial. The question of law related to whether Janssen co...
Read more
January 19, 2023

Janssen v. Pharmascience

Counsel: Peter Wilcox and Marian Wolanski

We successfully represented Janssen in a motion brought by the appellant (Pharmascience) to settle the contents of the appeal book in the context of an appeal from the judgment of the Federal Court in Janssen Inc. v. Pharmascience Inc., 2022 FC 1218 ...
Read more
January 24, 2023

Alexion v. Attorney General of Canada

Counsel: Peter Wilcox, Marian Wolanski and Kelly Zhang

This was an application to add an inventor to two patents owned by Alexion Pharmaceuticals. The patents relate to Alexion’s blockbuster drug SOLIRIS. The application was granted, ensuring that the correct inventors are named on the patents relating t...
Read more
February 14, 2023

Apotex Inc. v Janssen Inc. et al

Counsel: Peter Wilcox, Stephanie Anderson, Heather Lindsay and Kelly Zhang

We successfully represented Janssen on these motions seeking non-party discovery in three PMNOC section 8 actions.Each of Apotex, Dr. Reddy’s and Pharmascience resisted, on numerous grounds, non-party discovery for use in these section 8 actions. The...
Read more
August 23, 2022

Janssen v. Pharmascience

Counsel: Peter Wilcox, Marian Wolanski, Megan Pocalyuko and Oleyna Strigul

We successfully represented Janssen in defending the validity of the patent relating to Janssen’s INVEGA SUSTENNA® (paliperidone palmitate) once-monthly injection product used to treat schizophrenia.
Read more
January 31, 2022

Janssen v Apotex

Counsel: Peter Wilcox, Marian Wolanski and Megan Pocalyuko

We successfully represented Janssen in this summary trial in the Federal Court on infringement issues against Apotex in respect of Janssen’s patent covering its important INVEGA SUSTENNA® (paliperidone palmitate) once-monthly injection product used t...
Read more
January 19, 2022

Janssen v Pharmascience

Counsel: Peter Wilcox, Marian Wolanski and Megan Pocalyuko

We successfully represented Janssen in this summary trial in the Federal Court on infringement issues against Pharmascience in respect of Janssen’s patent covering its important INVEGA SUSTENNA® (paliperidone palmitate) once-monthly injection product...
Read more
January 14, 2021

Janssen v Apotex, Pharmascience and Dr. Reddy’s Laboratories

Counsel: Peter Wilcox, Marian Wolanski, Stephanie Anderson and Megan Pocalyuko

We represented Janssen and BTG in these patent infringement actions relating to Janssen’s prostate cancer product ZYTIGA®(abiraterone acetate). We were successful in proving inducing infringement and in resisting the defendants’ attacks based on lack...
Read more
July 28, 2021

Seedlings v. Pfizer

Counsel: Peter Wilcox and Stephanie Anderson

We successfully represented Pfizer on this appeal related to a mechanical device patent and Pfizer’s epinephrine auto injector product EpiPen®. The Federal Court of Appeal upheld the trial judge’s decision on claim construction, anticipation, obvious...
Read more
July 13, 2018

Eli Lilly Canada Inc. et al v. Apotex Inc.

Counsel: Marian Wolanski

We represented Eli Lilly, Daiichi and Ube in this application relating to a patent covering Eli Lilly’s EFFIENT product.
Read more
March 04, 2021

Apotex v. Janssen

Counsel: Peter Wilcox and Stephanie Anderson

We successfully represented Janssen on this appeal. The Federal Court of Appeal upheld the trial judge’s decision that the patent was valid and infringed. On validity, the Court clarified the nature of evidence that can be used to establish demonstra...
Read more
January 14, 2021

Elea v Simplot

Counsel: Peter Wilcox

We successfully represented Elea on this appeal. J.R Simplot, the defendant in a patent infringement action brought by McCain, had issued a third party claim against Elea, alleging that Elea was responsible for any damages that Simplot may be require...
Read more
January 02, 2020

Seedlings Life Sciences v Pfizer

Counsel: Peter Wilcox and Marian Wolanski

We successfully represented Pfizer in this patent infringement action. Seedlings – a non-practicing entity – alleged that Pfizer’s EpiPen infringed a Seedlings patent. Seedlings was seeking all of the profits earned by Pfizer on EpiPen sales since 20...
Read more

See all cases

Awards

Consistently Recognized
for Excellence.

We are consistently recognized as leading IP litigators in Canada. Among others, we are recognized by:

Legal 500 Canada Elite Boutique 2025
Best Law Firms - Canada Tier 1 for Intellectual Property Law 2025
Chambers Recognized for Intellectual Property: Litigation 2025
IAM Patent 1000 Recognized for Patent Litigation 2024
Chambers Recognized for Intellectual Property: Litigation 2024
Legal 500 Canada Elite Boutique 2024
LMG Life Science Patent Impact Case of the Year: Teva v. Janssen (2023 FCA 68) 2023
Lexpert® MOST FREQUENTLY RECOMMENDED FOR INTELLECTUAL PROPERTY LITIGATION 2023

See all awards

Persuasive Advocacy.Proven Results.

News

Our Team

Our cases

Awards

Consistently Recognizedfor Excellence.

Persuasive Advocacy.
Proven Results.

Consistently Recognized
for Excellence.